Home » Topics » BioWorld Science

BioWorld Science
RSS

Minimal radiation exposure to staff seen with Iomab-B in phase III SIERRA trial

July 19, 2019

Phase I plans for NTRX-07, a highly selective and potent CB2 receptor agonist

July 19, 2019

Phase I study of Novo Nordisk's NNC-0247-0829 begins

July 19, 2019

Adaptimmune starts SURPASS study with its next-generation SPEAR T cells targeting MAGE-A4

July 19, 2019

AC Immune initiates phase I study of ACI-3024

July 19, 2019

CCL5 as novel biomarker associated with poor prognosis in locally advanced pancreatic cancer

July 19, 2019

Phase III portion of the LUME-Meso study does not meet primary endpoint

July 19, 2019

Immune cell stress response may play role in chronic pain

July 19, 2019

For whom the pain bell Tolls

July 19, 2019

AMP analogues with reduced toxicity

July 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...